Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

AZD3514 MeSH Supplementary Concept Data 2025


MeSH Supplementary
AZD3514
Unique ID
C583656
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C583656
Entry Term(s)
6-(4-(4-(2-(4-acetylpiperazin-1-yl)ethoxy)phenyl)piperidin-1-yl)-3-(trifluoromethyl)-7,8-dihydro(1,2,4)triazolo(4,3-b)pyridazine
Registry Numbers
0
Heading Mapped to
*Pyridazines
Frequency
8
Note
in Phase I clinical trial in patients with castrate-resistant prostate cancer (2/2013); structure in first source
Source
Bioorg Med Chem Lett. 2013 Apr 1;23(7):1945-8
Date of Entry
2013/09/26
Revision Date
2013/09/26
AZD3514 Preferred
6-(4-(4-(2-(4-acetylpiperazin-1-yl)ethoxy)phenyl)piperidin-1-yl)-3-(trifluoromethyl)-7,8-dihydro(1,2,4)triazolo(4,3-b)pyridazine Broader
page delivered in 0.006s